Reciprocal effects of Guizhi decoction (桂枝汤) to the Guizhi decoction syndrome by toll-like receptor mRNA expression and cytokines secretion

[1]  T. Wynn,et al.  Obstacles and opportunities for understanding macrophage polarization , 2011, Journal of leukocyte biology.

[2]  A. Salazar,et al.  Antiviral role of toll-like receptor-3 agonists against seasonal and avian influenza viruses. , 2009, Current pharmaceutical design.

[3]  R. Sun,et al.  TLR-9 Activation Aggravates Concanavalin A-Induced Hepatitis via Promoting Accumulation and Activation of Liver CD4+ NKT Cells1 , 2009, The Journal of Immunology.

[4]  O. Kämpe,et al.  Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis , 2008, European journal of immunology.

[5]  N. Fukuishi,et al.  Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. , 2008, Biological & pharmaceutical bulletin.

[6]  T. Ishii,et al.  Dissociation of Toll-like receptor 2-mediated innate immune response to Zymosan by organic solvent-treatment without loss of Dectin-1 reactivity. , 2008, Biological & pharmaceutical bulletin.

[7]  H. Huo,et al.  Effects of 3-phenyl-propenal on the expression of toll-like receptors and downstream signaling components on raw264.7 murine macrophages. , 2008, The American journal of Chinese medicine.

[8]  Byung Hun Kim,et al.  In vitro immunoregulatory effects of Korean mistletoe lectin on functional activation of monocytic and macrophage-like cells. , 2007, Biological & pharmaceutical bulletin.

[9]  O. Hazeki,et al.  Role of phosphoinositide 3-kinase in innate immunity. , 2007, Biological & pharmaceutical bulletin.

[10]  L. Parker,et al.  Translational Mini‐Review Series on Toll‐like Receptors:
Networks regulated by Toll‐like receptors mediate innate and adaptive immunity , 2007, Clinical and experimental immunology.

[11]  M. O’Riordan,et al.  Innate recognition of intracellular bacteria. , 2007, Current opinion in immunology.

[12]  H. Huo,et al.  [Effect of Shensu Yin on the expression of toll-like receptors and the downstream signaling components on RAW 264.7 cells]. , 2007, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[13]  K. Michelsen,et al.  Toll-like receptors and innate immunity in gut homeostasis and pathology , 2007, Current opinion in hematology.

[14]  F. Romagné.  Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors. , 2007, Drug discovery today.

[15]  N. Ishimura,et al.  Therapeutic targeting of toll-like receptors in gastrointestinal inflammation. , 2006, Current pharmaceutical design.

[16]  J. Shupe,et al.  Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.

[17]  J. Andersen,et al.  TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein , 2005, Science.

[18]  Byung Hak Kim,et al.  Anti-inflammatory benzene diamine compound inhibited toll-like receptor 4-mediated inducible nitric oxide synthase expression and nuclear factor-kappa B activation. , 2005, Biological & pharmaceutical bulletin.

[19]  A. Schaeffer.  A Toll-Like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004 .

[20]  Yung-sun Song,et al.  Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-kappaB. , 2004, Biological & pharmaceutical bulletin.

[21]  R. Vabulas,et al.  Bacterial CpG‐DNA and lipopolysaccharides activate Toll‐like receptors at distinct cellular compartments , 2002, European journal of immunology.

[22]  F. Martinon,et al.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor , 2000, Nature Cell Biology.